4519 — Chugai Pharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Chugai Pharmaceutical Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	C2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	686,184	786,946	999,759	1,259,726	1,111,367
Cost of Revenue
Gross Profit	421,452	513,481	662,079	783,475	698,061
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	475,587	485,716	577,862	726,417	672,193
Operating Profit	210,597	301,230	421,897	533,309	439,174
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	207,893	298,188	419,385	531,166	443,821
Provision for Income Taxes
Net Income After Taxes	157,560	214,733	302,995	374,429	325,472
Net Income Before Extraordinary Items
Net Income	157,560	214,733	302,995	374,429	325,472
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	157,560	214,733	302,995	374,429	325,472
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	97.6	131	187	228	200
Dividends per Share